A detailed history of Custom Index Systems, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Custom Index Systems, LLC holds 14,415 shares of SLN stock, worth $259,325. This represents 0.14% of its overall portfolio holdings.

Number of Shares
14,415
Previous 14,836 2.84%
Holding current value
$259,325
Previous $282 Million 7.03%
% of portfolio
0.14%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$15.53 - $21.74 $6,538 - $9,152
-421 Reduced 2.84%
14,415 $262 Million
Q2 2024

Aug 06, 2024

BUY
$18.31 - $23.91 $271,647 - $354,728
14,836 New
14,836 $282 Million

Others Institutions Holding SLN

About Silence Therapeutics plc


  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $646M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track Custom Index Systems, LLC Portfolio

Follow Custom Index Systems, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Custom Index Systems, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Custom Index Systems, LLC with notifications on news.